# Ecallantide (Kalbitor)

Source: https://ourhealthnetwork.com/drugs/ecallantide
Data: FDA Orange Book and OpenFDA, refreshed periodically

## What is Ecallantide?

Ecallantide (brand name: Kalbitor) is a plasma kallikrein inhibitor. It is prescribed to treat angioedemas, hereditary.

## Brand names

Kalbitor

## Indications

Ecallantide is prescribed for the treatment of angioedemas and hereditary.

## Conditions treated

- [Angioedemas](https://ourhealthnetwork.com/conditions/angioedemas)
- [Hereditary](https://ourhealthnetwork.com/conditions/hereditary)

## Mechanism of action

Hereditary angioedema (HAE) is a rare genetic disorder caused by mutations to C1-esterase-inhibitor (C1-INH) located on Chromosome 11q and inherited as an autosomal dominant trait. HAE is characterized by low levels of C1-INH activity and low levels of C4.

## Drug classification

- Established Pharmacologic Class: Plasma Kallikrein Inhibitor [EPC]
- Mechanism of Action class: Kallikrein Inhibitors [MoA]
- Route of administration: SUBCUTANEOUS

## Common side effects

and pyrexia, diarrhea, e were headache, fatigue, injection site reactions, nasopharyngitis, nausea, pruritus

## Sources and disclaimers

- FDA Orange Book and OpenFDA dataset
- This information is for educational purposes only and does not constitute medical advice. Always consult a healthcare professional before starting, stopping, or changing any medication.

## Related

- [All drugs](https://ourhealthnetwork.com/drugs)
- [Find specialists who prescribe this drug](https://ourhealthnetwork.com/find-doctors)
- [Methodology](https://ourhealthnetwork.com/methodology)